Clinical Trial Update: Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult. [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study evaluating SYN006 with Pulmicort pMDI and Meptin Air in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Meptin Air (ipratropium bromide)
• Pulmicort pMDI (budesonide)
• SYN006

Snippet

Sponsor: Intech Biopharm Ltd. | Conditions: Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED